|
|
|
Volumn 24, Issue 2, 2004, Pages
|
|
Competitiveness Key for Europe's Bioindustry
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AS 1404;
AS 1406;
BEXAAR;
CYC 202;
CYC 682;
CYCLIN DEPENDENT KINASE INHIBITOR;
FLUOROURACIL;
GEMCITABINE;
IBRITUMOMAB TIUXETAN;
MONOCLONAL ANTIBODY;
MUCIN 1;
R 1549;
R 1550;
RIBONUCLEASE;
TGN 167;
TGN 212;
TGN 255;
THROMBIN INHIBITOR;
TOSITUMOMAB I 131;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
ANTICOAGULATION;
APOPTOSIS;
ARTICLE;
BIOTECHNOLOGY;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CELL PROLIFERATION;
CLINICAL TRIAL;
COMPETITIVE ABILITY;
DRUG TOLERABILITY;
EUROPE;
EUROPEAN UNION;
FINANCIAL MANAGEMENT;
GLOMERULONEPHRITIS;
HUMAN;
ISOTOPE LABELING;
LAW;
ONCOGENE NEU;
OVARY CANCER;
STOMACH CANCER;
THROMBOSIS;
TUMOR VASCULARIZATION;
CORDIA;
|
|
EID: 0742286874
PISSN: 02706377
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|